P&G has started to explore 3D bioprinting, which could provide a quicker and cheaper way to test its products for toxicity and efficacy. The FT reports.
P&G has started to explore 3D bioprinting, which could provide a quicker and cheaper way to test its products for toxicity and efficacy. The FT reports.